Identification of senescence‐related genes in Parkinson's disease reveals candidate therapeutic targets and pathological processes

BACKGROUND: Parkinson's disease (PD), a progressive neurodegenerative disease, is closely linked to the aging process; however, its precise molecular mechanisms remain unclear. This work aimed at clarifying the function of senescence-related genes (SRGs) in PD and investigating their molecular underpinnings, as well as their potential diagnostic and therapeutic significance. METHODS: By integrating bioinformatics with experimental validation, the CellAge database provided 278 SRGs for this study. A total of 2925 differentially expressed genes (DEGs) and 31 differentially expressed SRGs (DESRGs) were identified, which are mainly involved in signaling pathways, including nuclear factor kappa light chain enhancer of activated B cells (NF-κB) and interleukin 17 (IL-17). Through protein-protein interaction (PPI) network analysis, 10 hub genes were identified, such as IRF7, IFNG, and BCL6. RESULTS: In PD mouse and MN9D cell models by D-galactose (D-gal) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), combined treatment (D-gal + MPTP) synergistically reduced tyrosine hydroxylase (TH) expression, promoted α-synuclein (α-syn) aggregation, aggravated cellular senescence, and caused significant upregulation of IRF7, whereas IRF7 small interfering RNA (siRNA) intervention reversed senescence- and PD-related pathological changes. Molecular docking analyses identified candidate small molecules targeting hub genes, including fostamatinib and ropsacitinib. In vitro experiments provided preliminary support that these compounds modulated SYK and TYK2 proteins and alleviated pathological phenotypes in cellular models. CONCLUSIONS: Overall, this study demonstrates that D-gal-induced aging-like stress accelerates PD-related pathological progression by activating multiple signaling pathways, including JAK-STAT, AGE-RAGE, and NF-κB, thereby promoting inflammation, oxidative stress, and neuronal dysfunction. Key genes including IRF7 may serve as candidate biomarkers, providing preliminary evidence for the role of senescence-like stress in PD pathogenesis.

Authors

Institutions

Publication Details

Journal
Animal Models and Experimental Medicine
Published
2026-06-30
DOI
https://doi.org/10.1002/ame2.70240
Primary Topic
Antioxidants, Aging, Portulaca oleracea
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of senescence‐related genes in Parkinson's disease reveals candidate therapeutic targets and pathological processes

T Liu, 程相树, Jianshe Wei, Haojie Wu
Animal Models and Experimental Medicine
Antioxidants, Aging, Portulaca oleracea
article

Identification of senescence‐related genes in Parkinson's disease reveals candidate therapeutic targets and pathological processes

T Liu, 程相树, Jianshe Wei, Haojie Wu
article en

Abstract

BACKGROUND: Parkinson's disease (PD), a progressive neurodegenerative disease, is closely linked to the aging process; however, its precise molecular mechanisms remain unclear. This work aimed at clarifying the function of senescence-related genes (SRGs) in PD and investigating their molecular underpinnings, as well as their potential diagnostic and therapeutic significance. METHODS: By integrating bioinformatics with experimental validation, the CellAge database provided 278 SRGs for this study. A total of 2925 differentially expressed genes (DEGs) and 31 differentially expressed SRGs (DESRGs) were identified, which are mainly involved in signaling pathways, including nuclear factor kappa light chain enhancer of activated B cells (NF-κB) and interleukin 17 (IL-17). Through protein-protein interaction (PPI) network analysis, 10 hub genes were identified, such as IRF7, IFNG, and BCL6. RESULTS: In PD mouse and MN9D cell models by D-galactose (D-gal) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), combined treatment (D-gal + MPTP) synergistically reduced tyrosine hydroxylase (TH) expression, promoted α-synuclein (α-syn) aggregation, aggravated cellular senescence, and caused significant upregulation of IRF7, whereas IRF7 small interfering RNA (siRNA) intervention reversed senescence- and PD-related pathological changes. Molecular docking analyses identified candidate small molecules targeting hub genes, including fostamatinib and ropsacitinib. In vitro experiments provided preliminary support that these compounds modulated SYK and TYK2 proteins and alleviated pathological phenotypes in cellular models. CONCLUSIONS: Overall, this study demonstrates that D-gal-induced aging-like stress accelerates PD-related pathological progression by activating multiple signaling pathways, including JAK-STAT, AGE-RAGE, and NF-κB, thereby promoting inflammation, oxidative stress, and neuronal dysfunction. Key genes including IRF7 may serve as candidate biomarkers, providing preliminary evidence for the role of senescence-like stress in PD pathogenesis.

Animal Models and Experimental Medicine
Henan University (CN)
Good health and well-being
Openalex Percentile: Top 10%
Antioxidants, Aging, Portulaca oleracea
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.